News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
458,296 Results
Type
Article (24090)
Company Profile (157)
Press Release (434049)
Multimedia
Podcasts (75)
Webinars (11)
Section
Business (145028)
Career Advice (1324)
Deals (25965)
Drug Delivery (103)
Drug Development (54779)
Employer Resources (99)
FDA (10067)
Job Trends (11171)
News (242232)
Policy (23646)
Tag
2024 BioCapital Digital (9)
2024 BioForest Digital (4)
2024 BioForest Standard (1)
2024 BioMidwest Digital (5)
2024 BioMidwest Standard (2)
2024 Bio NC Digital (3)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (7)
2024 Biotech Beach Digital (4)
2024 Biotech Beach Standard (2)
2024 Genetown Digital (3)
2024 Genetown Standard (5)
2024 Lone Star Bio Digital (5)
2024 Pharm Country Digital (4)
2024 Pharm Country Standard (2)
2025 BioForest Digital (4)
2025 Lone Star Bio Digital (4)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Standard (1)
Academia (1394)
Accelerated approval (3)
Adcomms (22)
Allergies (52)
Alliances (38827)
ALS (56)
Alzheimer's disease (803)
Antibody-drug conjugate (ADC) (95)
Approvals (10076)
Artificial intelligence (190)
Autoimmune disease (15)
Automation (8)
Bankruptcy (237)
Best Places to Work (8570)
BIOSECURE Act (17)
Biosimilars (105)
Biotechnology (69)
Bladder cancer (40)
Brain cancer (20)
Breast cancer (146)
Cancer (1340)
Cardiovascular disease (130)
Career advice (1088)
Career pathing (22)
CAR-T (82)
Cell therapy (225)
Cervical cancer (14)
Clinical research (45502)
Collaboration (588)
Compensation (345)
Complete response letters (23)
COVID-19 (1664)
CRISPR (27)
C-suite (176)
Cystic fibrosis (61)
Data (1328)
Decentralized trials (2)
Denatured (20)
Depression (30)
Diabetes (158)
Diagnostics (4146)
Digital health (11)
Diversity (9)
Diversity, equity & inclusion (25)
Drug discovery (91)
Drug pricing (116)
Drug shortages (31)
Duchenne muscular dystrophy (63)
Earnings (53060)
Editorial (36)
Employer branding (15)
Employer resources (90)
Events (64300)
Executive appointments (567)
FDA (10849)
Featured Employer (28)
Friedreich's ataxia (3)
Frontotemporal dementia (1)
Funding (428)
Gene editing (58)
Generative AI (20)
Gene therapy (176)
GLP-1 (632)
Government (3372)
Grass and pollen (4)
Guidances (34)
Healthcare (12257)
Huntington's disease (13)
IgA nephropathy (20)
Immunology and inflammation (92)
Indications (22)
Infectious disease (1772)
Inflammatory bowel disease (97)
Inflation Reduction Act (8)
Influenza (37)
Intellectual property (68)
Interviews (195)
IPO (10655)
IRA (47)
Job creations (2920)
Job search strategy (955)
Kidney cancer (7)
Labor market (25)
Layoffs (326)
Leadership (15)
Legal (5626)
Liver cancer (40)
Lung cancer (198)
Lymphoma (102)
Machine learning (2)
Management (35)
Manufacturing (250)
MASH (51)
Medical device (6308)
Medtech (6311)
Mergers & acquisitions (15700)
Metabolic disorders (528)
Multiple sclerosis (55)
NASH (20)
Neurodegenerative disease (57)
Neuropsychiatric disorders (21)
Neuroscience (1157)
NextGen: Class of 2025 (4556)
Non-profit (2898)
Northern California (1391)
Now hiring (22)
Obesity (321)
Opinion (207)
Ovarian cancer (39)
Pain (70)
Pancreatic cancer (46)
Parkinson's disease (99)
Partnered (16)
Patents (163)
Patient recruitment (54)
Peanut (24)
People (44806)
Pharmaceutical (80)
Pharmacy benefit managers (21)
Phase I (14124)
Phase II (19379)
Phase III (15487)
Pipeline (883)
Policy (144)
Postmarket research (1773)
Preclinical (5074)
Press Release (70)
Prostate cancer (72)
Psychedelics (24)
Radiopharmaceuticals (183)
Rare diseases (271)
Real estate (4776)
Recruiting (38)
Regulatory (16166)
Reports (24)
Research institute (1301)
Resumes & cover letters (209)
Rett syndrome (1)
RNA editing (2)
RSV (29)
Schizophrenia (63)
Series A (66)
Series B (42)
Service/supplier (17)
Sickle cell disease (42)
Southern California (1311)
Special edition (16)
Spinal muscular atrophy (117)
Sponsored (21)
Startups (2493)
State (2)
Stomach cancer (9)
Supply chain (63)
Tariffs (29)
The Weekly (53)
United States (13677)
Vaccines (394)
Venture capitalists (29)
Weight loss (249)
Women's health (22)
Worklife (10)
Date
Today (20)
Last 7 days (307)
Last 30 days (1575)
Last 365 days (21762)
2025 (6218)
2024 (23132)
2023 (26053)
2022 (34789)
2021 (37284)
2020 (36951)
2019 (33181)
2018 (25475)
2017 (22728)
2016 (21711)
2015 (24934)
2014 (19367)
2013 (16396)
2012 (17758)
2011 (18357)
2010 (16660)
Location
Africa (542)
Alabama (31)
Alaska (5)
Arizona (113)
Arkansas (10)
Asia (29674)
Australia (3956)
California (3293)
Canada (1500)
China (367)
Colorado (167)
Connecticut (162)
Delaware (97)
Europe (63640)
Florida (555)
Georgia (94)
Hawaii (1)
Idaho (33)
Illinois (389)
India (22)
Indiana (224)
Iowa (6)
Japan (126)
Kansas (76)
Kentucky (21)
Louisiana (6)
Maine (27)
Maryland (613)
Massachusetts (2600)
Michigan (115)
Minnesota (199)
Mississippi (2)
Missouri (45)
Montana (18)
Nebraska (16)
Nevada (33)
New Hampshire (28)
New Jersey (1291)
New Mexico (24)
New York (933)
North Carolina (693)
North Dakota (5)
Northern California (1391)
Ohio (142)
Oklahoma (10)
Oregon (24)
Pennsylvania (830)
Puerto Rico (11)
Rhode Island (22)
South America (804)
South Carolina (5)
Southern California (1311)
Tennessee (72)
Texas (524)
Utah (82)
Virginia (107)
Washington D.C. (56)
Washington State (289)
West Virginia (3)
Wisconsin (35)
458,296 Results for "johnson matthey pharma services".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Compensation
Top 6 Highest-Paid Pharma CEOs in 2024
Johnson & Johnson’s Joaquin Duato is no longer the highest paid CEO in pharma. Meanwhile, just two women make the top 10.
April 16, 2025
·
7 min read
·
Annalee Armstrong
Johnson Matthey signs agreement to sell its Medical Device Components business for US$700m
Johnson Matthey Plc (JM) announces that it has signed a definitive agreement to sell 100% of its Medical Device Components business (MDC) to Montagu Private Equity (Montagu) for cash consideration of US$700 million (£550 million) on a cash free debt free basis.
March 20, 2024
·
4 min read
Manufacturing
J&J Joins Pharma Peers With $55B US Manufacturing Boost Following Trump’s Tariff Threats
Johnson & Johnson follows Eli Lilly in spending billions on U.S. manufacturing after President Donald Trump threatened major tariffs on pharmaceutical products. Pfizer has also promised a similar commitment.
March 21, 2025
·
2 min read
·
Annalee Armstrong
Business
New Jersey’s Life Sciences Scene Continues Expanding Beyond Big Pharma
Known as the home of big-name companies including Johnson & Johnson, New Jersey has become a destination for more and more small and midsize life sciences businesses. Choose New Jersey, Grace Therapeutics and Onyx Equities executives discuss the state’s life sciences scene.
April 10, 2025
·
6 min read
·
Angela Gabriel
Press Releases
Johnson & Johnson Reports Q1 2025 Results
April 15, 2025
·
23 min read
Business
Five Biggest Drug Face-Offs in Pharma History
Wegovy and Zepbound are just the latest drug dyads to face-off in the competitive pharma market, continuing a legacy of rivalry that includes blockbuster drugs Keytruda, Humira and Eliquis.
April 9, 2025
·
9 min read
·
Tristan Manalac
Press Releases
Johnson & Johnson to Participate in the BofA Securities 2025 Healthcare Conference
April 7, 2025
·
1 min read
Press Releases
Johnson & Johnson MedTech Announces Completion of First Cases with OTTAVA™ Robotic Surgical System
April 14, 2025
·
6 min read
Press Releases
Johnson & Johnson Announces Expected Closing Date for Intra-Cellular Acquisition
April 2, 2025
·
4 min read
European Commission approves Johnson & Johnson’s subcutaneous DARZALEX® (daratumumab)-based quadruplet regimen for the treatment of patients with newly diagnosed multiple myeloma, regardless of transplant eligibility
April 7, 2025
·
14 min read
1 of 45,830
Next
